To examine whether RNA-FISH is applicable to human samples, we analyzed 104 BC samples independently by RNA-FISH and Sanger sequencing to detect FGFR3-TACC3 fusions as a prospective cohort study. This evidence concerns the gene FGFR3 and breast cancer.